Week Ending March 15, 2021

A Population-Based Intervention to Improve Care Cascades of Patients With Hepatitis C Virus Infection
“Hepatitis C virus (HCV) infection is common in the United States and leads to significant morbidity, mortality, and economic costs. Simplified screening recommendations and highly effective direct-acting antivirals for HCV present an opportunity to eliminate HCV. The objective of this study was to increase testing, linkage to care, treatment, and cure of HCV. This was an observational, prospective, population-based intervention program carried out between September 2014 and September 2018 and performed in three community health centers, three large multiclinic health care systems, and an HCV patient education and advocacy group in King County, WA.”

NC prisons must test and treat inmates for hepatitis C under class-action settlement
“After three inmates sued the North Carolina Department of Public Safety for failing to treat their hepatitis C, all prisoners will have access to testing and treatment of the virus.”

COVID-19 hits viral hepatitis care for vulnerable populations
“On Jan 6, 2021, the UK Department of Health and Social Care in England (DHSC) and Public Health England (PHE) released updated guidance for commissioners and providers of services for people who use drugs or alcohol, calling for the reinstatement of testing and treatment for hepatitis C virus (HCV), which might have been curtailed by the COVID-19 pandemic.”

People With HIV and Hepatitis B Need Ongoing Liver Cancer Monitoring
“People with HIV and hepatitis B virus coinfection remain at risk for developing hepatocellular carcinoma (HCC) despite antiviral treatment, and they should undergo regular monitoring for liver cancer, according to research presented at the virtual Conference on Retroviruses and Opportunistic Infections (CROI).”

WHA’s president outlines plans to improve treatments for patients with hepatitis
“Danjuma Adda, a Nigerian public health expert, became the president-elect of the World Hepatitis Alliance (WHA) in November last year. He is the first African to hold the position. Having been infected and lost his mother to hepatitis B, Adda’s personal experience has fueled his passion and drive for a paradigm shift in fighting the liver disease, which the WHO estimates affects 60 million Africans.”